Skip to main content
SHIFT Newsroom

Why NHS weight-loss medicine access varies

Published 24 September 2026 ·

You may be able to get weight-loss medicine through the NHS, but there is no single UK eligibility rule. The medicine, reason for treatment, health conditions, BMI and local service all matter. Meeting a published BMI threshold does not confirm that a prescription is suitable or available.

For the current NHS eligibility rules and the difference between specialist services and England's phased primary-care rollout, see our NHS weight-loss medication pathways guide.

The useful first step is to ask your GP practice or local weight-management service which assessment route is available and what help you can get now. You can ask for weight-management support even if you do not qualify for a particular injection. The NHS explains the wider support options, including programmes, medicines and specialist assessment.

Information checked on 5 October 2026. This is an editorial explanation of official guidance, not an individual assessment or an independent clinical review.

Why three different eligibility answers can all appear online

A medicine's licence describes its authorised use. A NICE recommendation describes the circumstances in which NHS use is recommended. Commissioning and local delivery concern the funded service, assessment route and implementation timetable. These are separate questions.

For example, NICE TA1026 recommends tirzepatide for weight management in adults with an initial BMI of at least 35 kg/m² and at least one weight-related condition, alongside dietary and activity support. Lower BMI thresholds, usually reduced by 2.5 kg/m², apply for specified ethnic backgrounds. England's primary-care rollout initially prioritises a narrower group.

That is why “NICE recommends it” and “your practice cannot currently offer it” can describe different parts of the pathway. Ask which rule is being applied, rather than assuming that one online calculator settles it.

NHS weight-loss injections: the key distinctions

These are summaries of the weight-management appraisals, not a complete prescribing checklist or a promise of local availability.

MedicineMain distinction in NICE weight-management guidance
Tirzepatide, also called MounjaroTA1026: initial BMI at least 35 plus a weight-related condition; relevant ethnicity adjustments. England has phased primary-care access.
Semaglutide, also called WegovyTA875: a weight-related condition plus BMI at least 35, or BMI 30–34.9 with the specified specialist-referral criteria. Specialist provision and a maximum two-year course apply under this appraisal; relevant ethnicity adjustments apply.
Liraglutide, also called SaxendaTA664: BMI at least 35, non-diabetic hyperglycaemia (raised blood sugar below the diabetes range) and high cardiovascular risk, through a specialist service; relevant lower BMI thresholds apply.

Read the full tirzepatide, semaglutide and liraglutide guidance for the conditions attached to each recommendation. These medicines are not the whole NHS pathway: other options include orlistat and non-medicine support.

The reason for prescribing matters too. Diabetes treatment has different criteria. There is also a separate NICE semaglutide recommendation for cardiovascular risk reduction, TA1152, published in May 2026. Do not apply the TA875 weight-management restrictions to every possible semaglutide indication. Ask your clinician which guidance applies to your care.

England: what the phased tirzepatide rollout means now

As checked on 5 October 2026, the published primary-care cohorts include:

Access cohortBMI before relevant ethnicity adjustmentQualifying conditions
Cohort 1, introduced firstAt least 40At least four of the five conditions below
Cohort 2, introduced from 23 June 202635–39.9At least four of the five conditions below

The five conditions are type 2 diabetes, hypertension, cardiovascular disease, obstructive sleep apnoea and dyslipidaemia (abnormal blood fats). The BMI adjustment is 2.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds. The service checks the applicable diagnostic definitions.

The current NHS Cheshire and Merseyside patient guidance sets out these cohorts and makes clear that practice participation and availability can vary. The NHS England Digital cohort appendix also distinguishes the rollout cohorts. Specialist-service access is a separate route; ask whether it applies to you.

Later expansion is planned, but a future cohort is not current eligibility. Check the NHS England patient information and your local service when seeking an assessment.

Your GP appointment checklist

You do not need to arrive knowing which medicine to request. Arrive ready to explain what is difficult and what you want help with.

Prepare one short note:

A useful opening is: “I'd like help managing my weight. Can we review the support available and whether I need a specialist assessment?”

Ask these five questions:

  1. Which weight-management service can assess me, and do I need a referral or can I refer myself?
  2. If medicine is considered, which eligibility and local access rules apply now?
  3. Who would prescribe and review it, and whom would I contact between appointments?
  4. What dietary, activity or behavioural support comes with treatment, and what support can I get while waiting?
  5. What happens if treatment is unsuitable, causes problems, does not help enough or ends?

Before leaving, ask for the next action, who is responsible and when to check back. “Wait for contact” is easier to manage when you know which service will contact you and how to follow up.

Scotland, Wales and Northern Ireland

England's cohort timetable is not a UK-wide rule.

A medicine recommendation in another nation does not establish your local access.

If the answer is “not currently available”

Ask what the reason is: clinical suitability, current rollout criteria, referral requirements or service availability. Then ask what support can be offered instead and whether circumstances that affect access will be reviewed.

The NHS lists options for finding local support, including checking your practice website and, in England, your Integrated Care Board website. Some programmes accept self-referrals. NHS Better Health also provides free resources.

Pick a manageable starting point, such as planning one regular meal, and discuss activity suited to your health. Avoid extreme restriction while waiting. If low mood, pain or eating difficulties are part of the problem, say so: support should take the whole situation into account.

Private treatment does not automatically transfer to the NHS. If you already have a prescriber, ask about transfer arrangements before ending that care and bring your treatment records.

Common questions

Can my GP prescribe a weight-loss injection?

Some tirzepatide weight-management prescribing is delivered through primary care in England. Your practice must confirm its arrangements and assess suitability. Other routes may involve specialist services.

Is BMI 35 enough to qualify?

No. The medicine's recommendation, related conditions, treatment indication, relevant ethnicity adjustment and current service pathway all matter.

Can I still ask for help if I do not qualify?

Yes. Ask about weight-management programmes, practical support and assessment of conditions that make weight difficult to manage. An injection threshold is not a threshold for deserving help.

For more background, read our Mounjaro UK information and Wegovy UK information. You can also explore our weight-management guide for men.

For a broader explanation of routes, see our NHS weight-loss medication pathways guide. For your next appointment, use the checklist above and confirm one clear next step.

Editorial update — 5 October 2026: the original publication date is retained. This revision clarifies current access cohorts, separates treatment indications and adds an appointment checklist and national information routes. It does not certify individual eligibility.

Take clear questions to the conversation

Use the free review checklist to organise questions about available support and what happens next. It cannot confirm NHS eligibility, arrange a referral or promise access to a medicine.

Build your weight-management review checklist

Last updated .